hFCGR1A/hFCGR2B
Nomenclature
C57BL/6JSmo-Fcgr1tm3(hFCGR1A)Fcgr2btm3(hFCGR2B)Smoc
Cat. NO.
NM-XA-253155
Strain State
Repository Live
Model Description
Validation Data
Fig.1 Detection of FCGR1A expression in subcutaneous fat pad, bladder and liver by RT-PCR. Subcutaneous fat pad, bladder and liver RNA was extracted from 8-week-old male WT C57BL/6 (WT)(n=2) and homozygous hFCGR1A/hFCGR2B mice (HO/WT) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.
Abbr. M, marker; HO, homozygous; WT, wild type.
Fig.2 Detection of FCGR2B expression in liver, brain, spleen and bone marrow by RT-PCR. Liver, brain, spleen and bone marrow RNA was extracted from 12-week-old male wild-type C57BL/6 (WT)(n=2) and heterozygous hFCGR1A/hFCGR2B mice (HE/HE) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.
Abbr. M, marker; HE, heterozygous; WT, wild type.
Fig.3 Detection of hFCGR2B and mFCGR2B expression on macrophages,monocytes and B cells in spleen of WT C57BL/6 mice and WT/HO hFCGR1A/hFCGR2B mice by FACS.
Leukocytes were collected from wild-type C57BL/6 mice (female, 8 weeks old) and WT/HO hFCGR1A/hFCGR2B humanized mice (female, 9 weeks old), and analyzed by flow cytometry with anti-mCD32 and anti-hCD32.
Abbr. HO, homozygous; WT, wild type.
Fig.4 Detection of hFCGR2B and mFCGR2B expression on macrophages,monocytes and B cells in blood of WT C57BL/6 mice and WT/HO hFCGR1A/hFCGR2B mice by FACS.
Leukocytes were collected from wild-type C57BL/6 mice (female, 8 weeks old) and WT/HO hFCGR1A/hFCGR2B humanized mice (female, 9 weeks old), and analyzed by flow cytometry with anti-mCD32 and anti-hCD32.
Abbr. HO, homozygous; WT, wild type.
You may also like
Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreShanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
